Mr. Robert Lee Lolik, LISW-CP Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 2 Marshland Rd, Hilton Head Island, SC 29926 Phone: 843-683-3311 Fax: 843-686-3009 |
Mr. Gregory Taylor Killian, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 151 Dillon Rd, Hilton Head Island, SC 29926 Phone: 843-681-4865 Fax: 843-689-6267 |
Ann Marie Martel, M.S.W., LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2 Shelter Cove Ln, #262 Captain's Quarters, Hilton Head Island, SC 29928 Phone: 843-785-5995 Fax: 843-785-5995 |
Cheryl Ganser, MA, LISW-CP Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 400 Main St Ste 100a13, Hilton Head Island, SC 29926 Phone: 704-540-0802 |
Mrs. Patricia Anne Thrasher, MED Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 19 Shelter Cove Ln, Suite 204, Hilton Head Island, SC 29928 Phone: 843-341-9369 Fax: 843-341-9331 |
Lisette Cifaldi, LISW-CP Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23c Shelter Cove Ln, Hilton Head Island, SC 29928 Phone: 803-463-1010 |
News Archive
While the use of opioids after surgery is intended as a short-term strategy to relieve pain, many patients who weren't prior opioid users continue to take the medication for several months after their lung operations, becoming dependent and "persistent opioid users," according to research presented today at the 54th Annual Meeting of The Society of Thoracic Surgeons.
Hotspots in two areas of a gene that encodes a specific signaling enzyme, or kinase, are vulnerable to a variety of mutations found in five types of brain cancers, according to a report published in the August 1 issue of the journal Cancer Research.
Delcath Systems, Inc., announced today that the first patients in Germany have been treated with the Delcath Hepatic CHEMOSAT Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the Company announced with the hospital in December 2011.
Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today that it has priced its public offering of 10,000,000 common shares at $5.75 per common share. Sinovac has granted the underwriters a 30-day over-allotment option to purchase up to an additional 1,500,000 common shares on the same terms and conditions.
› Verified 4 days ago